Bentham Science Logo

Current Drug Safety

Volume 14, 3 Issues, 2019
ISSN: 2212-3911 (Online)
ISSN: 1574-8863 (Print)
This journal supports open access
Order Your Article Before Print

Aims & Scope

Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, full-length/mini reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.

Current Drug Safety

,

Volume 14

-

Number 1



Biography   Open Access



Preface   Open Access



Review Article



Review Article



Research Article



Research Article   Open Access



Research Article



Case Report

Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report

, 14(1): 37 - 39

Aashiq Ahamed Shukkoor, Saravanan Thangavelu*, Nimmy Elizabeth George and Shanmuga Priya


DOI: 10.2174/1574886313666180731123232
View Abstract


Articles Ahead of Print




A “Crazy Paving” Pattern on CT Scan in A Patient Treated with Pembrolizumab


Maurizio Marvisi*, Sara Ramponi, Laura Balzarini and Chiara Mancini


View Abstract View on PubMed





Significant Weight Loss in a Patient Taking Olmesartan: An Unusual Case Report


Andromachi Makri, Matilda Florentin*, Moses S. Elisaf and George Liamis


View Abstract View on PubMed



Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin


Dhruvkumar M. Patel, Mukundkumar V. Patel *, Akash D. Patel, Jignesh C. Kaklotar , Greshaben R. Patel and Maitri M. Patel


View Abstract View on PubMed


Abstracts Ahead of Print

Editor's Choice





Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature

, 2017; 12(3): 193 - 197

Shelby L. Register, Orlando L. Ruano, Deborah L. Sanchez, Glenn Catalano* and Maria C. Catalano


DOI: 10.2174/1574886312666170710190820
Abstract



Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders

, 2017; 12(2): 76 - 94

George Badavanis*, Efstathia Pasmatzi, Alexandra Monastirli and Dionysios Tsambaos


DOI: 10.2174/1574886312666170518124014
Abstract



Ovarian Stimulation, Intrauterine Insemination, Multiple Pregnancy and Major Congenital Malformations: A Systematic Review and Meta- Analysis- The ART_Rev Study

, 2016; 11(3): 222 - 261

Sonia Chaabane, Odile Sheehy, Patricia Monnier, William Fraser, François Bissonnette, Jaquetta M. Trasler, Flory T. Muanda, Takoua Boukhris, Fatiha Karam, Fabiano Santos, Lucie Blais and Anick Bérard


DOI: 10.2174/1574886311666160627094051
Abstract



Perioperative Safety of Warfarin Therapy and Reversal

, 2016; 11(2): 149 - 155

Benjamin Maslin, Erin Springer, Richard Zhu, Vijay Kodumudi and Nalini Vadivelu


DOI: 10.2174/1574886311666151217121553
Abstract



Biologic Therapy in Psoriasis: Safety Profile

, 2016; 11(1): 4 - 11

Anna Campanati, Giulia Ganzetti, K. Giuliodori, Elisa Molinelli and A. Offidani


DOI: 10.2174/1574886310666151014115532
Abstract



New Oral Anticoagulants and Their Reversal

, 2015; 10(3): 208 - 216

Ian Pinto, Anshu Giri, Umbreen Arshad and Ajeet Gajra


DOI: 10.2174/1574886310666150416123530
Abstract



Open Access Articles

Comparison of the Effects of Metoprolol and Bisoprolol on Lipid and Glucose Profiles in Cardiovascular Patients

, 2019; 14(1): 27 - 30

Ahmad Abdulrahman Almeman*, Yasir Ahmed Beshir and Ahmad Hamad Aldosary


Abstract



Register-based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children

, 2018; 13(2): 107 - 112

Miia Artama*, Hanna Rinta-Kokko, Hanna Nohynek, Jukka Jokinen and Arto A. Palmu


Abstract


Pharmacotherapy of Persons with Dementia in Long-term Care in Australia: A Descriptive Audit of Central Nervous System Medications

, 2017; 12(2): 95 - 102

Wendy Moyle*, Najwan El Saifi, Brian Draper, Cindy Jones, Elizabeth Beattie, David Shum, Lukman Thalib, Cindy Mervin and Siobhan O’Dwyer


Abstract


Prescription Opioid Abuse and its Potential Role in Gross Dental Decay

, 2017; 12(1): 22 - 26

Andrew D. Fraser, Boshi Zhang, Hassan Khan, Henry Ma and Elliot V. Hersh


Abstract


Validation of Acute Liver Injury Cases in a Population-Based Cohort Study of Oral Antimicrobial Users

, 2014; 9(1): 23 - 28

Christine L. Bui, James A. Kaye, Jordi Castellsague, Brian Calingaert, Lisa J. McQuay, Nuria Riera-Guardia, Catherine W. Saltus, Scott C. Quinlan, Crystal N. Holick, Peter M. Wahl, Kiliana Suzart, Kenneth J. Rothman, Mari-Ann Wallander and Susana Perez-Gutthann


Abstract


Use of Metformin and Survival of Diabetic Women with Breast Cancer

, 2013; 8(5): 357 - 363

Paul JHL Peeters, Marloes T. Bazelier, Peter Vestergaard, Hubert G.M. Leufkens, Marjanka K. Schmidt, Frank de Vries and Marie L. De Bruin


Abstract


Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies

, 2013; 8(5): 333 - 348

Oystein Karlstad, Jacob Starup Linde, Peter Vestergaard, Vidar Hjellvik, Marloes T Bazelier, Marjanka K Schmidt, Morten Andersen, Anssi Auvinen, Jari Haukka, Kari Furu, Frank de Vries and Marie L De Bruin


Abstract


CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis

, 2013; 8(5): 296 - 332

Jakob Starup-Linde, Øystein Karlstad, Stine Aistrup Eriksen, Peter Vestergaard, Heleen K. Bronsveld, Frank de Vries, Morten Andersen, Anssi Auvinen, Jari Haukka, Vidar Hjellvik, Marloes T. Bazelier, Anthonius de Boer, Kari Furu and Marie L. De Bruin


Abstract



Zopiclone as Positive Control in Studies Examining the Residual Effects of Hypnotic Drugs on Driving Ability

, 2011; 6(4): 209 - 218

Joris C. Verster, D. Warren Spence, Azmeh Shahid, Seithikurippu R. Pandi-Perumal and Thomas Roth


Abstract



Most Cited Articles

Review Article

Risks associated with SGLT2 inhibitors: An overview

, 2018; 13(2): 84-91.

Mahakpreet Singh and Anoop Kumar*


DOI: 10.2174/1574886313666180226103408
Abstract



Case Studies

A probable topiramate-induced limbs paraesthesia and rigid fingers flexion

, 2018; 13(2): 131-136.

Andrea Domenico Pratico*, Martino Ruggieri, Raffaele Falsaperla and Piero Pavone


DOI: 10.2174/1574886313666180213090445
Abstract


Case Studies

Dolutegravir-related neurological adverse events: A case report of successful management with therapeutic drug monitoring

, 1 March 2018; 13(1): 69-71.

Francois Parant*, Patrick Miailhes, Florence Brunel and Marie-Claude Gagnieu


DOI: 10.2174/1574886313666180116124046
Abstract


Review Article

Musculoskeletal and rheumatic diseases induced by immune checkpoint inhibitors: A review of the literature

, 2018; 13(3): 150-164.

Devis Benfaremo, Lucia Manfredi , Michele Maria Luchetti* and Armando Gabrielli


DOI: 10.2174/1574886313666180508122332
Abstract



Review Article

Vaping versus smoking: A quest for efficacy and safety of E-cigarette

, 2018; 13(2): 92-101.

Harmeet Singh Rehan*, Jahnavi Maini and Amrit Pal Singh Hungin


DOI: 10.2174/1574886313666180227110556
Abstract


Research Article

Safety of vinflunine in patients with advanced urothelial carcinoma refractory to platinum-based chemotherapy: A prospective pilot study

, 2019; 14(1): 31-36.

Raafat Abdel-Malek, Kyrillus S. Shohdy*, Noha Abbas, Mohamed Ismail, Emad Hamada and Yasser Abdel-Kader


DOI: 10.2174/1574886313666181001120752
Abstract



Review Article

Cutaneous adverse events of immune checkpoint inhibitors: A summarized overview

, 2019; 14(1): 14-20.

Kerasia-Maria Plachouri *, Eleftheria Vryzaki and Sophia Georgiou


DOI: 10.2174/1574886313666180730114309
Abstract


Case Report

Biperiden-induced delirium in a five-years old child

, 2019; 14(1): 48-50.

Duygu Kınay and Ahmet Zihni Soyata*


DOI: 10.2174/1574886313666181029101830
Abstract


Case Studies

Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study

, 2018; 13(3): 200-207.

Andrea D. Pratico*, Laura Longo, Silvana Mansueto, Lucia Gozzo, Ignazio Barberi, Venera Tiralongo, Vincenzo Salvo, Raffaele Falsaperla, Giovanna Vitaliti, Mario La Rosa, Salvatore Leonardi, Antonio Rotondo, Nicoletta Avola, Debora Sgarlata, Annalisa Damiano, Massimo Tirantello, Gaspare Anzelmo, Domenico Cipolla, Angelo Rizzo, Antonio Russo, Martino Ruggieri, Salvatore Salomone and Filippo Drago


DOI: 10.2174/1574886313666180619120406
Abstract



Case Studies

Cyclophosphamide and/or anthracyclines induced epiphora in breast cancer patients: A rare side-effect

, 1 March 2018; 13(1): 62-64.

Ruchika Kalra, Bhavesh Chavada, Nishant R. Madhani, Bhargav Purohit* and C.B. Tripathi


DOI: 10.2174/1574886312666170919175614
Abstract


Research Article

Knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process among health care providers in Dammam, Saudi Arabia

, 1 March 2018; 13(1): 21-25.

Mohammad Daud Ali*, Yousif Amin Hassan, Ayaz Ahmad, Orjwan Alaqel, Hadeel Al-Harbi and Nada Mohammed Al-Suhaimi


DOI: 10.2174/1574886313666171218123802
Abstract



Most Accessed Articles

Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation

, 2019; 14(1): 67-71.

Benedetto Caroleo, Maria Cristina Caroleo, Antonio Cimellaro, Lidia Colangelo, Maria Perticone, Giulio Di Mizio, Giovambattista De Sarro and Luca Gallelli*


DOI: 10.2174/1574886313666181116100452
Abstract


Prescription Opioid Abuse and its Potential Role in Gross Dental Decay

, 2017; 12(1): 22-26.

Andrew D. Fraser, Boshi Zhang, Hassan Khan, Henry Ma and Elliot V. Hersh


DOI: 10.2174/1574886311666160803111401
Abstract





Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

, 2016; 11(1): 62-68.

Assunta Sgambato, Francesca Casaluce, Paola C. Sacco, Giovanni Palazzolo, Paolo Maione, Antonio Rossi, Fortunato Ciardiello and Cesare Gridelli


DOI: 10.2174/1574886311207040289
Abstract





Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice

, 2016; 11(1): 86-98.

Guillermo A. Keller, Paulino A. Alvarez, Marcelo L. Ponte, Waldo H. Belloso, Claudia Bagnes, Cecilia Sparanochia, Claudio D. Gonzalez, M. Cecilia Villa Etchegoyen, Roberto A. Diez and Guillermo Di Girolamo


DOI: 10.2174/1574886311207040262
Abstract



Editor-in-Chief

Dr. Seetal Dodd
University of Melbourne
Geelong, Melbourne
Australia

About the Journal

⇨ Journal Home⇨ Editorial Policies⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers

For Authors

⇨ Author Guidelines⇨ Animated Abstracts⇨ Submit Abstracts Online⇨ Submit Manuscripts Online⇨ Open Access Funding⇨ Publishing Ethics and Rectitude⇨ Self-Archiving Policies⇨ Manuscript Transfer Facility

For Guest Editors

⇨ Thematic Issue Proposal⇨ Special Thematic Issues⇨ Guest Editor Guidelines

For Reviewers

⇨ Reviewer Guidelines⇨ Peer Review Workflow⇨ Become a Reviewer

For Librarians & Readers

⇨ Contents & Abstracts⇨ Open Access Articles⇨ Free Copies Online⇨ Most Accessed Articles⇨ Purchase Articles⇨ Order Reprints⇨ Subscribe⇨ Trial Requests⇨ Library Recommendation

Quick Links

⇨ Journal's New Website⇨ Advertise with Us⇨ Download PDF Flyer⇨ Table of Contents Alert

Journal History

Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.11

Related Journals

Related eBooks

eBooks Catalog

Webmaster Contact: info@benthamscience.net
Copyright © 2019 Bentham Science | Privacy Policy